DOMPE'
Dompe' Farmaceutici Spa
Trademark Registered: 2016-04-26
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79165147 |
| Registration Number | 4943605 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Elizabeth E. Brenckman |
| Attorney Docket Number | 28545-0004US |
| Law Office Assigned | N20 |
| Employee Name | JONES, JACQUELYN ANDRE |
Timeline
| 2015-03-12 | Application Filed |
| 2016-02-09 | Published for Opposition |
| 2016-04-26 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-04-26 | Status: Live/Registered |
| 2016-04-26 | Trademark Registered |
| 2019-04-04 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  DOMPE' FARMACEUTICI SPA |
| Address | Via S. Martino della Battaglia, 12 I-20122 MILANO IT |
| Legal Entity Type | Joint Stock Company |
| Legal Entity State | IT |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive-cold pharmaceutical preparations for use in chemotherapy; pharmaceutical preparation for the treatment of rare diseases; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | 2015-05-14 | 1 SDRC M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2015-05-15 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-05-18 | 3 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2015-05-22 | 4 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2015-06-17 | 5 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2015-06-18 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2015-06-19 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2015-06-22 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2015-06-22 | 9 RFCS P: |
| REFUSAL PROCESSED BY IB | 2015-07-11 | 10 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-12-07 | 11 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-12-07 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-12-10 | 13 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-12-29 | 14 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-01-20 | 15 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2016-01-20 | 16 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2016-01-20 | 17 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2016-02-05 | 18 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2016-02-09 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-02-09 | 20 NPUB E:E-Mail |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2016-03-17 | 21 ADCH M: |
| REGISTERED-PRINCIPAL REGISTER | 2016-04-26 | 22 R.PR A:Allowance for Publication |
| NEW REPRESENTATIVE AT IB RECEIVED | 2016-04-28 | 23 NREP P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2016-07-26 | 24 FICR P: |
| FINAL DISPOSITION PROCESSED | 2016-07-27 | 25 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-07-27 | 26 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2016-08-12 | 27 FINO P: |
| INTERNATIONAL REGISTRATION RENEWED | 2019-04-04 | 28 RNWL P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-02-12 | 29 NREP P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2021-04-26 | 30 REM3 E:E-Mail |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2021-06-04 | 31 ADCH M: |
| TEAS SECTION 71 RECEIVED | 2022-10-26 | 32 ES71 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-05-16 | 33 APRE A:Allowance for Publication |
| REGISTERED-SEC.71 ACCEPTED | 2023-05-18 | 34 71AG O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2023-05-18 | 35 NA71 E:E-Mail |
| PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | 2024-01-18 | 36 INPR P: |
| INVALIDATION PROCESSED | 2024-01-29 | 37 INPC P: |
| PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2024-01-29 | 38 INPS P: |
| PARTIAL INVALIDATION PROCESSED BY THE IB | 2024-02-25 | 39 INNP P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 